12/26
07:11 am
docs
Healthcare In 2025: A Year Of Practical AI, Remote Care And Patient-Centered Solutions [Forbes]
Low
Report
Healthcare In 2025: A Year Of Practical AI, Remote Care And Patient-Centered Solutions [Forbes]
12/24
10:29 am
docs
4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow [Yahoo! Finance]
Low
Report
4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow [Yahoo! Finance]
12/23
08:24 pm
docs
Doximity (DOCS) Ascends But Remains Behind Market: Some Facts to Note [Yahoo! Finance]
Low
Report
Doximity (DOCS) Ascends But Remains Behind Market: Some Facts to Note [Yahoo! Finance]
12/20
07:36 am
docs
Doximity, Inc. (NASDAQ: DOCS) is now covered by analysts at Stephens. They set an "equal weight" rating and a $55.00 price target on the stock.
Medium
Report
Doximity, Inc. (NASDAQ: DOCS) is now covered by analysts at Stephens. They set an "equal weight" rating and a $55.00 price target on the stock.
12/19
09:00 pm
docs
DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Medium
Report
DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
12/18
10:52 am
docs
Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Medium
Report
Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
12/17
08:17 am
docs
Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care [Yahoo! Finance]
Low
Report
Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care [Yahoo! Finance]
12/17
08:00 am
docs
Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care
Low
Report
Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care
12/17
06:27 am
docs
The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte [Yahoo! Finance]
Low
Report
The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte [Yahoo! Finance]
12/16
04:19 pm
docs
Prescription for Profits: 3 Must-Buy Healthcare Stocks Before 2025 [Yahoo! Finance]
Low
Report
Prescription for Profits: 3 Must-Buy Healthcare Stocks Before 2025 [Yahoo! Finance]
12/10
09:32 am
docs
Doximity (DOCS) Management Regained Investors Trust Through Solid Execution [Yahoo! Finance]
Low
Report
Doximity (DOCS) Management Regained Investors Trust Through Solid Execution [Yahoo! Finance]
12/10
08:14 am
docs
ViaLase and the John A. Moran Eye Center Announce Research Partnership to Accelerate Glaucoma Research and Innovation [Yahoo! Finance]
Low
Report
ViaLase and the John A. Moran Eye Center Announce Research Partnership to Accelerate Glaucoma Research and Innovation [Yahoo! Finance]
12/4
07:33 am
docs
Doximity, Inc. (NASDAQ: DOCS) is now covered by analysts at Mizuho. They set a "neutral" rating and a $55.00 price target on the stock.
Low
Report
Doximity, Inc. (NASDAQ: DOCS) is now covered by analysts at Mizuho. They set a "neutral" rating and a $55.00 price target on the stock.
12/2
03:48 pm
docs
Are Medical Stocks Lagging Doximity (DOCS) This Year? [Yahoo! Finance]
Low
Report
Are Medical Stocks Lagging Doximity (DOCS) This Year? [Yahoo! Finance]
12/2
07:01 am
docs
At US$53.00, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely? [Yahoo! Finance]
Low
Report
At US$53.00, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely? [Yahoo! Finance]
11/21
10:21 am
docs
Doximity, Inc. (NASDAQ: DOCS) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $48.00. They now have a "neutral" rating on the stock.
Medium
Report
Doximity, Inc. (NASDAQ: DOCS) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $48.00. They now have a "neutral" rating on the stock.
11/20
07:07 am
docs
Zacks.com featured highlights Doximity, Impinj and Innodata [Yahoo! Finance]
Medium
Report
Zacks.com featured highlights Doximity, Impinj and Innodata [Yahoo! Finance]
11/18
10:29 pm
docs
TikTok ‘dermfluencers' have medical students flocking to dermatology, where they can make half a million dollars a year and work four days a week [Yahoo! Finance]
Low
Report
TikTok ‘dermfluencers' have medical students flocking to dermatology, where they can make half a million dollars a year and work four days a week [Yahoo! Finance]
11/18
08:09 pm
docs
TikTok ‘dermfluencers' have medical students flocking to dermatology, where they can make half a million dollars a year and work four days a week [Fortune]
Low
Report
TikTok ‘dermfluencers' have medical students flocking to dermatology, where they can make half a million dollars a year and work four days a week [Fortune]
11/18
09:34 am
docs
Polen U.S. Small Company Growth Strategy Exited Doximity (DOCS) Due to Multiple Factors [Yahoo! Finance]
Medium
Report
Polen U.S. Small Company Growth Strategy Exited Doximity (DOCS) Due to Multiple Factors [Yahoo! Finance]
11/15
01:50 pm
docs
Surging Earnings Estimates Signal Upside for Doximity (DOCS) Stock [Yahoo! Finance]
Low
Report
Surging Earnings Estimates Signal Upside for Doximity (DOCS) Stock [Yahoo! Finance]
11/15
08:03 am
docs
Doximity, Inc. (NASDAQ: DOCS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $58.00 price target on the stock.
Medium
Report
Doximity, Inc. (NASDAQ: DOCS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $58.00 price target on the stock.
11/15
06:59 am
docs
Doximity's (NYSE:DOCS) Strong Earnings Are Of Good Quality [Yahoo! Finance]
Medium
Report
Doximity's (NYSE:DOCS) Strong Earnings Are Of Good Quality [Yahoo! Finance]
11/14
11:47 am
docs
Doximity upgraded to equal weight by Morgan Stanley [Seeking Alpha]
Low
Report
Doximity upgraded to equal weight by Morgan Stanley [Seeking Alpha]
11/14
11:13 am
docs
Doximity, Inc. (NASDAQ: DOCS) had its price target raised by analysts at Truist Financial Co. from $35.00 to $49.00. They now have a "hold" rating on the stock.
Low
Report
Doximity, Inc. (NASDAQ: DOCS) had its price target raised by analysts at Truist Financial Co. from $35.00 to $49.00. They now have a "hold" rating on the stock.